 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This price move could indicate a change in the trend, and may be a buy signal for investors...

Merus (MRUS, $24.09) price moved above its 50-day Moving Average on September 27, 2023

This is a signal that MRUS's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Merus (MRUS, $24.09) Stochastic Oscillator left the oversold zone on September 27, 2023

Merus (MRUS, $22.77) Stochastic Oscillator left the oversold zone on September 26, 2023

This is a Bearish indicator signaling MRUS's price could decline from here. Traders may explore shorting the stock or put options...

Merus (MRUS, $22.6) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 25, 2023

This indicator may be signaling that MRUS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Merus (MRUS, $22.6) entered Downtrend as Momentum indicator drops below 0 level on Sep 25, 2023

Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases PR Newswire VANCOUVER, British Columbia, Sept...

Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases

This price move could indicate a change in the trend, and may be a sell signal for investors...

Merus (MRUS, $23.95) price exceeded its 50-day Moving Average on September 22, 2023

Needham  Company LLC reissued their buy rating on shares of Merus (NASDAQ:MRUS  Free Report) in a report published on Thursday, Benzinga reports. The firm currently has a $45.00 price...

Merus (NASDAQ:MRUS) Earns Buy Rating from Needham & Company LLC

Merus (MRUS, $24.13) price exceeded its 50-day Moving Average on September 13, 2023

Merus (MRUS, $24.39) price moved above its 50-day Moving Average on September 12, 2023

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. The company was founded by Ton Logtenberg and Hennie Hoogenboom on June 16, 2003 and is headquartered in Utrecht, the Netherlands.

Watchers	800
52-Wk Low	$12.03
52-Wk High	$27.70

Market Cap	$1.39B
Volume (M)	474,792.00
52-Wk High	$27.70
52-Wk Low	$12.03

MRUS Merus N.V

About

Feed

News

Sentiment

Earnings

Fundamentals